Answers are grounded in this paper and cite their sources.
Background and Objectives: Normative modeling expresses an individual's brain measures as deviations from a large healthy reference and has been advanced as a route to precision imaging biomarkers in epilepsy, where structural abnormality is distributed rather than confined to the presumed focus. Whether this framework can inform clinical classification from clinically acquired T1-weighted and diffusion MRI is untested. We asked whether normative deviations discriminate between (1) epilepsy and functional seizures; (2) focal and generalized epilepsy; and (3) drug-resistant and drug-responsive epilepsy. Methods: We retrospectively studied patients with epilepsy or functional seizures without comorbid epilepsy who underwent 3-Tesla epilepsy-protocol MRI at the University of Pennsylvania. Morphometric deviation scores (cortical thickness, subcortical volume) were derived from CentileBrain (n>37,000 healthy references). White matter fractional anisotropy and mean diffusivity profiles were referenced to harmonized Human Connectome Project cohorts. Lobar composites, hemispheric asymmetry indices, and whole-tract means were compared with rank-sum tests; discrimination was summarized as area under the ROC curve (AUC) with bootstrap confidence intervals and Benjamini-Hochberg correction. Whole-brain deviation burden was examined as a secondary analysis. Minimum detectable effects were estimated by Monte Carlo simulation at 80% power (α=0.05). Results: We included 273 patients with epilepsy (203 focal, 37 generalized, 33 unclassified; 97 drug-resistant, 176 drug-responsive) and 32 with functional seizures. In the primary analyses, no regional or tract-level normative measure distinguished epilepsy from functional seizures, focal from generalized epilepsy, or drug-resistant from drug-responsive epilepsy; AUCs did not exceed 0.62, with upper confidence limits up to 0.72. In the secondary analysis, whole-brain morphometric deviation burden was modestly higher in epilepsy than in functional seizures (AUC 0.66, 95% CI 0.57-0.74) but did not separate the within-epilepsy comparisons. The study could detect AUC ≥0.65 for epilepsy versus functional seizures, ≥0.64 for focal versus generalized, and ≥0.60 for drug-resistant versus drug-responsive epilepsy. Discussion: Univariate normative deviation summaries from clinical MRI do not currently distinguish these groups well enough to guide care. Whole-brain deviation burden, the only summary measure that differed after correction, was detectable at the group level but insufficient for individual-level classification. Progress may require network-targeted analysis of patient-specific deviations and multimodal integration.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: